36 related articles for article (PubMed ID: 11079158)
1. Computational design and experimental discovery of an antiestrogenic peptide derived from alpha-fetoprotein.
Kirschner KN; Lexa KW; Salisburg AM; Alser KA; Joseph L; Andersen TT; Bennett JA; Jacobson HI; Shields GC
J Am Chem Soc; 2007 May; 129(19):6263-8. PubMed ID: 17441722
[TBL] [Abstract][Full Text] [Related]
2. Structure and function of alpha-fetoprotein.
Tomasi TB
Annu Rev Med; 1977; 28():453-65. PubMed ID: 67821
[TBL] [Abstract][Full Text] [Related]
3. The dual targeting of insulin and insulin-like growth factor 1 receptor enhances the mTOR inhibitor-mediated antitumor efficacy in hepatocellular carcinoma.
Pivonello C; Negri M; De Martino MC; Napolitano M; de Angelis C; Provvisiero DP; Cuomo G; Auriemma RS; Simeoli C; Izzo F; Colao A; Hofland LJ; Pivonello R
Oncotarget; 2016 Mar; 7(9):9718-31. PubMed ID: 26756219
[TBL] [Abstract][Full Text] [Related]
4. Screening and Identifying a Novel ssDNA Aptamer against Alpha-fetoprotein Using CE-SELEX.
Dong L; Tan Q; Ye W; Liu D; Chen H; Hu H; Wen D; Liu Y; Cao Y; Kang J; Fan J; Guo W; Wu W
Sci Rep; 2015 Oct; 5():15552. PubMed ID: 26497223
[TBL] [Abstract][Full Text] [Related]
5. Telomerase inhibition decreases alpha-fetoprotein expression and secretion by hepatocellular carcinoma cell lines: in vitro and in vivo study.
Tahtouh R; Azzi AS; Alaaeddine N; Chamat S; Bouharoun-Tayoun H; Wardi L; Raad I; Sarkis R; Antoun NA; Hilal G
PLoS One; 2015; 10(3):e0119512. PubMed ID: 25822740
[TBL] [Abstract][Full Text] [Related]
6. Silencing alpha-fetoprotein inhibits VEGF and MMP-2/9 production in human hepatocellular carcinoma cell.
Meng W; Li X; Bai Z; Li Y; Yuan J; Liu T; Yan J; Zhou W; Zhu K; Zhang H; Li Y
PLoS One; 2014; 9(2):e90660. PubMed ID: 24587407
[TBL] [Abstract][Full Text] [Related]
7. The protective effect of parity in hormone receptor-positive, Ki-67 expressing breast cancer.
Lee SK; Kim SW; Han SA; Kil WH; Lee JE; Nam SJ
World J Surg; 2014 May; 38(5):1065-9. PubMed ID: 24481994
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of Cancer Growth Suppression of Alpha-Fetoprotein Derived Growth Inhibitory Peptides (GIP): Comparison of GIP-34 versus GIP-8 (AFPep). Updates and Prospects.
Mizejewski GJ
Cancers (Basel); 2011 Jun; 3(2):2709-33. PubMed ID: 24212829
[TBL] [Abstract][Full Text] [Related]
9. Alpha-fetoprotein: a renaissance.
Terentiev AA; Moldogazieva NT
Tumour Biol; 2013 Aug; 34(4):2075-91. PubMed ID: 23765762
[TBL] [Abstract][Full Text] [Related]
10. Alcohol-induced alterations in maternal uterine endothelial proteome: a quantitative iTRAQ mass spectrometric approach.
Ramadoss J; Magness RR
Reprod Toxicol; 2012 Dec; 34(4):538-44. PubMed ID: 22960358
[TBL] [Abstract][Full Text] [Related]
11. Birth weight, breast cancer and the potential mediating hormonal environment.
Bukowski R; Chlebowski RT; Thune I; Furberg AS; Hankins GD; Malone FD; D'Alton ME
PLoS One; 2012; 7(7):e40199. PubMed ID: 22815728
[TBL] [Abstract][Full Text] [Related]
12. Alpha-fetoprotein: from a diagnostic biomarker to a key role in female fertility.
De Mees C; Bakker J; Szpirer J; Szpirer C
Biomark Insights; 2007 Feb; 1():82-5. PubMed ID: 19690639
[TBL] [Abstract][Full Text] [Related]
13. Role for estradiol in female-typical brain and behavioral sexual differentiation.
Bakker J; Baum MJ
Front Neuroendocrinol; 2008 Jan; 29(1):1-16. PubMed ID: 17720235
[TBL] [Abstract][Full Text] [Related]
14. Alpha-fetoprotein controls female fertility and prenatal development of the gonadotropin-releasing hormone pathway through an antiestrogenic action.
De Mees C; Laes JF; Bakker J; Smitz J; Hennuy B; Van Vooren P; Gabant P; Szpirer J; Szpirer C
Mol Cell Biol; 2006 Mar; 26(5):2012-8. PubMed ID: 16479017
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy weight gain and breast cancer risk.
Kinnunen TI; Luoto R; Gissler M; Hemminki E; Hilakivi-Clarke L
BMC Womens Health; 2004 Oct; 4(1):7. PubMed ID: 15498103
[TBL] [Abstract][Full Text] [Related]
16. Alpha-foetoprotein in umbilical cord in relation to severe pre-eclampsia, birth weight and future breast cancer risk.
Vatten LJ; Romundstad PR; Odegård RA; Nilsen ST; Trichopoulos D; Austgulen R
Br J Cancer; 2002 Mar; 86(5):728-31. PubMed ID: 11875734
[TBL] [Abstract][Full Text] [Related]
17. Human alpha-fetoprotein peptides bind estrogen receptor and estradiol, and suppress breast cancer.
Vakharia D; Mizejewski GJ
Breast Cancer Res Treat; 2000 Sep; 63(1):41-52. PubMed ID: 11079158
[TBL] [Abstract][Full Text] [Related]
18. Alpha-fetoprotein derived synthetic peptides: assay of an estrogen-modifying regulatory segment.
Mizejewski GJ; Dias JA; Hauer CR; Henrikson KP; Gierthy J
Mol Cell Endocrinol; 1996 Apr; 118(1-2):15-23. PubMed ID: 8735587
[TBL] [Abstract][Full Text] [Related]
19. Alpha-fetoprotein derived from a human hepatoma prevents growth of estrogen-dependent human breast cancer xenografts.
Bennett JA; Zhu S; Pagano-Mirarchi A; Kellom TA; Jacobson HI
Clin Cancer Res; 1998 Nov; 4(11):2877-84. PubMed ID: 9829755
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
